Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Mariel Metcalfe
  • June 30, 2020
  • News

Research Partnership publishes new patient syndicated reports - Living with Ulcerative Colitis and Crohn’s Disease 2020

Research Partnership publishes new patient syndicated reports - Living with Ulcerative Colitis and Crohn’s Disease 2020

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the UC and CD patient journeys.   

read more »

How we conducted conference research to understand physician reactions to abstracts presented in a virtual setting

How we conducted conference research to understand physician reactions to abstracts presented in a virtual setting

Our client had planned to present new scientific data from its growing oncology portfolio and research pipeline at the Annual Meeting of The American Society of Clinical Oncology (ASCO).

Our client had planned to present new scientific data from its growing oncology portfolio and research pipeline at the Annual Meeting of The American Society of Clinical Oncology (ASCO). Data from a range of programmes were to be featured in more than 50 abstracts, including company-sponsored and collaborative research studies. However, as a result of the ongoing COVID-19 global pandemic, the annual event was converted from a physical setting to a virtual meeting. Market research was required to understand physician’s reaction to the abstracts presented in a virtual setting.

read more »

  • Posted by Claire Fradet Aubignat
  • June 29, 2020
  • Articles

Not just another PSP: 5 top tips for evaluating your patient support programme

Not just another PSP: 5 top tips for evaluating your patient support programme

Evaluating PSPs before launch is critical. We present you with our top tips for conducting successful market research to ensure your PSP is successful and maximises value to your customers.

Did you know that, whilst there are a significant number of PSPs available to patients, only a small minority are actually used?  IMS (2015) found that 36 out of almost 200,000 mobile health apps comprised 50% of downloads - many of the rest must have very few users. So, a key challenge is to develop a PSP that is utilised, valued and has a definite real world impact on both the patient and HCP experience.

read more »

How we supported forecasting for a new vaccine by identifying the optimal pricing strategy

How we supported forecasting for a new vaccine by identifying the optimal pricing strategy

Our client was looking to identify the price point that would maximise revenue from their new vaccine across 8 emerging markets in Latin America and Asia Pacific, as well as establish long-term projections for their forecasting model. In parallel, they needed to ensure widespread and rapid market penetration of the vaccine, taking into account factors such as consumer socio-economic group, age and household composition.
 

read more »

  • Posted by Pei Li Teh & Colin Tan
  • June 19, 2020
  • Webinars

Agile is a mind-set not a methodology

Agile is a mind-set not a methodology

We’ve all heard about how important it is to be agile. And the focus in pharmaceutical market research has been mainly on speed, and the methodologies and techniques that get us faster results. But we believe there’s more to being agile than just toolkits and technology.

read more »